# Validation of a Salivary miRNA Diagnostic Test for ASD

> **NCT05418023** · — · UNKNOWN · sponsor: **Quadrant Biosciences Inc.** · enrollment: 6604 (estimated)

## Conditions studied

- Autism Spectrum Disorder
- Developmental Delay

## Interventions

- **OTHER:** Salivary Collection
- **OTHER:** Adaptive Assessment
- **OTHER:** Medical and Demographic questionnaire
- **OTHER:** Autism Assessment
- **OTHER:** Intellectual Development Assessment

## Key facts

- **NCT ID:** NCT05418023
- **Lead sponsor:** Quadrant Biosciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-16
- **Primary completion:** 2023-07
- **Final completion:** 2023-07
- **Target enrollment:** 6604 (ESTIMATED)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05418023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05418023, "Validation of a Salivary miRNA Diagnostic Test for ASD". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05418023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*